I found this subject to be engaging, stimulating and overall a positive experience. As a Microbiology and Immunology major, there was no choice as to whether I took it or not; however, if I were to be given the choice, I would, undoubtedly.
The lecturers were, to varying degrees, clear and concise in the communication of complex concepts, and more than happy to answer any questions. I would advise any future students to pay particularly close attention to everything Sammy says in lectures (roughly a third of the subject). His slides are sparse, but his descriptions are not, and it is his descriptions that you will be assessed upon.
In terms of content, the first few weeks focus on Ig and TCR structure and genetics, the particulars of the innate immune response (PRRs, DC maturation and activation), and molecular immunology. This should be familiar to students who have taken the MIIM2000x subjects, and (presumably) those in Biomedicine, though of course it will be explored in greater depth. Be prepared to ratchet up a gear in the second half of semester, the subject definitely becomes more challenging, as the focus shifts to B- and T- Cell development, obscure, niche Lymphocyte variants; Immunopathology, and even a lecture on cutting-edge breakthroughs in cancer immunotherapy. There is a LOT to remember by the time June runs around, but if you manage to study consistently throughout the semester, don't fall behind, and tune in to the level of detail they expect of you, there is no reason you shouldn't do well.
The assessment was fair, and most people did reasonably well. The MSTs were 40 MCQ each, with 20 q's 'simple' style, and 20 'complex.' The exam was ~30 MCQ and a choice of 5 from 6 SAQ.
From the horse's mouth:
Highest mark: 98
Average: 67
H1: 36% of class, H2A: 9%, H2B: 9%, H3: 9%, Pass: 21% and Fail: 16%